# Jean-Pierre Delord

Source: https://onco.cc/people/jean-pierre-delord/  
OnCo record `jean-pierre-delord` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Medical oncologist who leads the IUCT Oncopole cooperation group in Toulouse and runs early-phase cancer drug trials.

## Summary

Jean-Pierre Delord is a professor of medical oncology and the administrator of the healthcare cooperation group (GCS) that runs IUCT Oncopole, the Toulouse university cancer institute combining the Oncopole Claudius Regaud and CHU de Toulouse teams. His research centres on early-phase clinical trials of new cancer drugs, including first-in-human studies such as the netrin-1 antibody programme published in Nature in 2023.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: leadership; clinician-scientist; early-phase trials; medical oncology
- Role: Administrator of the GCS (Groupement de Coopération Sanitaire)
- Specialisms: Medical oncology; Early-phase clinical trials; Head and neck cancer

## Sources

- Institution profile: https://www.iuct-oncopole.fr/la-gouvernance
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Delord+JP%5BAuthor%5D

## Connected records

- cancers: [Endometrial cancer](https://onco.cc/cancers/endometrial/), [Head and neck squamous cell carcinoma](https://onco.cc/cancers/head-and-neck/)
- institutions: [IUCT Oncopole (Institut Universitaire du Cancer de Toulouse)](https://onco.cc/institutions/iuct-oncopole/)

---
JSON: https://onco.cc/api/v1/entities/jean-pierre-delord.json